BC
NXTM

Barnett & Company’s NxStage Medical Inc. NXTM Stock Holding History

Barnett & Company’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-500
Closed -$14K – 363
2018
Q2 		$14K Hold
500
– – 0.01% 256
2018
Q1 		$12K Hold
500
– – 0.01% 264
2017
Q4 		$12K Hold
500
– – 0.01% 280
2017
Q3 		$14K Hold
500
– – 0.01% 269
2017
Q2 		$13K Hold
500
– – 0.01% 297
2017
Q1 		$13K Hold
500
– – 0.01% 276
2016
Q4 		$13K Hold
500
– – 0.01% 301
2016
Q3 		$12K Hold
500
– – 0.01% 324
2016
Q2 		$11K Hold
500
– – 0.01% 316
2016
Q1 		$7K Buy
+500
New +$8.38K ﹤0.01% 351

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Barnett & Company's NXTM Position: Q3 2018 in Review

Barnett & Company sold out of NxStage Medical Inc. (NXTM) in Q3 2018, closing a stake of 500 shares — an estimated $14K sold.

Barnett & Company first reported a position in NXTM in Q1 2016 and held it in 10 quarters. The position peaked at $14K in Q2 2018. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

  • Barnett & Company reported no remaining NxStage Medical Inc. position as of Q3 2018 after selling out during the quarter.
  • Barnett & Company sold 500 NxStage Medical Inc. shares in Q3 2018, an estimated $14K.
  • Barnett & Company first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 10 quarters.
  • Barnett & Company's NxStage Medical Inc. position peaked at $14K in Q2 2018.
  • 175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on Barnett & Company's 13F filing for Q3 2018, filed 2 Nov 2018.